D.E. Shaw & Co
ARNA

D.E. Shaw & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

D.E. Shaw & Co’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-35,000
Closed -$1.59M – 4395
2019
Q4 		$1.59M Buy
+35,000
New +$1.65M ﹤0.01% 2657

D.E. Shaw & Co's ARNA Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 228,325 shares — an estimated $21.2M sold.

D.E. Shaw & Co first reported a position in ARNA in Q4 2013 and held it in 21 quarters. The position peaked at $21.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • D.E. Shaw & Co reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 228,325 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $21.2M.
  • D.E. Shaw & Co first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 21 quarters.
  • D.E. Shaw & Co's Arena Pharmaceuticals Inc position peaked at $21.2M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.